1 |
Sanaie S, Nikanfar S, Kalekhane ZY, Azizi-Zeinalhajlou A, Sadigh-Eteghad S, Araj-Khodaei M, Ayati MH, Andalib S. Saffron as a promising therapy for diabetes and Alzheimer's disease: mechanistic insights. Metab Brain Dis 2023;38:137-62. [PMID: 35986812 DOI: 10.1007/s11011-022-01059-5] [Reference Citation Analysis]
|
2 |
Wang Y, Hu H, Liu X, Guo X. Hypoglycemic medicines in the treatment of Alzheimer's disease: Pathophysiological links between AD and glucose metabolism. Front Pharmacol 2023;14:1138499. [PMID: 36909158 DOI: 10.3389/fphar.2023.1138499] [Reference Citation Analysis]
|
3 |
Taylor MK, Sullivan DK, Keller JE, Burns JM, Swerdlow RH. Potential for Ketotherapies as Amyloid-Regulating Treatment in Individuals at Risk for Alzheimer’s Disease. Front Neurosci 2022;16:899612. [DOI: 10.3389/fnins.2022.899612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
4 |
El Gaamouch F, Lin H, Wang Q, Zhao W, Pan J, Liu K, Wong J, Wu C, Yuan C, Cheng H, Qin W, Hao K, Zhang B, Wang J. Peripheral and cognitive benefits of physical exercise in a mouse model of midlife metabolic syndrome. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07252-x] [Reference Citation Analysis]
|
5 |
Decourt B, D'Souza GX, Shi J, Ritter A, Suazo J, Sabbagh MN. The Cause of Alzheimer's Disease: The Theory of Multipathology Convergence to Chronic Neuronal Stress. Aging Dis 2022;13:37-60. [PMID: 35111361 DOI: 10.14336/AD.2021.0529] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
6 |
Lynn J, Park M, Ogunwale C, Acquaah-Mensah GK. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34842187 DOI: 10.3233/JAD-210612] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|